Note 17 - Stock-based Compensation and Other Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Year Ended December 31,
	2022		2021		2020
	(in thousands)
Stock-based compensation - equity awards	$	2,045	$	1,060	$	848
Stock-based compensation - liability awards		155		1,399		(734	)
Total stock-based compensation	$	2,200	$	2,459	$	114

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Year Ended December 31,
	2022			2021			2020
Weighted average exercise price - ($/share)	$	6.41		$	3.14		$	1.23
Expected life in years		6.0			6.0			6.0
Average expected volatility		72	%		75	%		74
Risk-free interest rate		1.98	%		0.95	%		0.42
Expected dividend yield		2.30	%		—			—
Weighted average grant date fair value - ($/share)	$	2.84		$	2.07		$	0.79

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Number of Shares Underlying Options			Weighted Average Exercise Price Per Share			Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	(in thousands)						(in years)		(in thousands)
Outstanding at January 1, 2022		359		$	1.96
Granted		241			6.41
Exercised		(47	)		(1.23	)
Unvested shares forfeited		(109	)		(4.03	)
Vested shares expired		—			—
Outstanding at December 31, 2022		444		$	3.95			7.15	$	632
Exercisable at December 31, 2022		147		$	1.83			3.92	$	400

	Number of Shares Underlying Options			Weighted Average Exercise Price Per Share			Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	(in thousands)						(in years)		(in thousands)
Outstanding at January 1, 2022		615		$	1.58
Granted		—			—
Exercised		(228	)		(1.12	)
Unvested shares forfeited		—			—
Vested shares expired		—			—
Outstanding at December 31, 2022		387		$	1.86			0.83	$	1,045
Exercisable at December 31, 2022		387		$	1.86			0.83	$	1,045

Nonvested Restricted Stock Shares Activity [Table Text Block]

	Restricted Stock			Weighted Average Grant Date Fair Value
	(in thousands)
Non-vested shares outstanding at January 1, 2022		741		$	2.36
Awards granted		384			6.56
Awards vested		(334	)		2.25
Awards forfeited		(126	)		3.68
Non-vested shares outstanding at December 31, 2022		665		$	4.59

	Restricted Stock			Weighted Average Conversion Date Fair Value
	(in thousands)
Non-vested shares outstanding at December 16, 2022		—		$	—
Awards converted		386			4.27
Awards vested		(3	)		4.27
Awards forfeited		—			—
Non-vested shares outstanding at December 31, 2022		383		$	4.27

Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]

	Restricted Stock		Weighted Average Conversion Date Fair Value
	(in thousands)
Non-vested shares outstanding at December 16, 2022		—	$	—
Awards converted		690		4.27
Awards vested		—		—
Awards forfeited		—		—
Non-vested shares outstanding at December 31, 2022		690	$	4.27

Share-Based Payment Arrangement, Deferred Shares, Activity [Table Text Block]

	Restricted Stock			Weighted Average Conversion Date Fair Value
	(in thousands)
Non-vested shares outstanding at December 16, 2022		—		$	—
Awards converted		460			4.27
Awards vested		(460	)		4.27
Awards forfeited		—			—
Non-vested shares outstanding at December 31, 2022		—		$	—

Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]

	Number of Shares Underlying SARs			Weighted Average Exercise Price Per Share		Term		Aggregate Intrinsic Value
	(in thousands)					(in years)		(in thousands)
Outstanding at January 1, 2022		362		$	1.81
Granted		—			—
Exercised		(160	)		1.74
Unvested SARs forfeited		—			—
Vested SARs expired		—			—
Outstanding at December 31, 2022		202		$	1.87		0.85	$	542
Exercisable at December 31, 2022		202		$	1.87		0.85	$	542